Recent onset vitiligo treated with systemic corticosteroid and topical tacrolimus: Need for early treatment in vitiligo

Journal of Dermatology

Volumn 37, Issue 12, 2010, Pages 1057-1059

  Lee, Dong Youn ^a   Kim, Cho Rok ^a   Lee, Joo Heung ^a   Yang, Jun Mo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; TACROLIMUS;

ADULT; APPETITE; CASE REPORT; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; INDIGESTION; LETTER; MALE; SIDE EFFECT; SKIN EXAMINATION; TREATMENT RESPONSE; VITILIGO;

ADULT; DERMATOLOGIC AGENTS; FACE; FACIAL DERMATOSES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDNISONE; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME; VITILIGO;

EID: 78649657853     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00929.x     Document Type: Letter

References (7)

1. TaÃeb A, Picardo M,. Clinical practice: Vitiligo. N Engl J Med 2009; 360: 160-169.
2. Brazzelli V, Antoninetti M, Palazzini S, Barbagallo T, De Silvestri A, Borroni G,. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. J Eur Acad Dermatol Venereol 2007; 21: 1369-1374.
3. Kim SM, Lee HS, Hann SK,. The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients. Int J Dermatol 1999; 38: 546-550.
4. Parsad D, Pandhi R, Dogra S, Kumar B,. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol 2004; 50: 63-67.
5. Ongenae K, Van Geel N, Naeyaert JM,. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003; 16: 90-100.
6. Caixia T, Hongwen F, Xiran L,. Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo. J Dermatol Sci 1999; 21: 59-62.
7. Xu AE, Zhang DM, Wei XD, Huang B, Lu LJ,. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo. Int J Dermatol 2009; 48: 86-90.